Workflow
青岛海尔生物医疗股份有限公司2024年年度权益分派实施公告

Core Viewpoint - The company announced a cash dividend distribution of CNY 0.47 per share for the fiscal year 2024, approved at the annual shareholders' meeting on April 29, 2025 [2][3]. Distribution Plan - The dividend distribution is based on the total share capital after deducting shares held in the company's repurchase account, resulting in a total of 313,425,953 shares eligible for the dividend [4][6]. - The total cash dividend to be distributed amounts to CNY 147,310,197.91 (including tax) [4]. - The cash dividend per share is calculated as approximately CNY 0.4633 after adjustments for the total share capital [6]. Implementation Details - The cash dividends will be distributed through China Securities Depository and Clearing Corporation Limited, Shanghai Branch, to shareholders registered by the end of the trading day on the record date [8]. - Shareholders who have not completed designated trading will have their dividends held by the clearing company until the trading is completed [8]. Taxation Information - Individual shareholders holding shares for over one year are exempt from personal income tax on dividends, while those holding for one year or less will have taxes calculated upon the sale of shares [10][11]. - For qualified foreign institutional investors (QFII), a withholding tax of 10% will apply, resulting in a net dividend of CNY 0.423 per share [12].